Prosperico Ventures

Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.

KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company offers a comprehensive range of biological heart valves, focusing on minimally invasive solutions that enhance patient outcomes. Utilizing cutting-edge technologies, including anti-calcification, dry presentation, and leaflet thinning, KingstronBio aims to deliver innovative and effective products to the medical community, thereby addressing critical needs in cardiovascular care.

Singlera Genomics Inc. specializes in developing genetic testing and molecular diagnostic technologies, particularly focusing on non-invasive methods. The company has created a methylation detection platform that enhances cancer screening for early tumor diagnosis and prevention. Its offerings include tumor diagnosis, personalized treatment options, non-invasive prenatal diagnosis, and pre-implantation genetic screening, along with customized scientific research services. With a commitment to precision medicine, Singlera Genomics aims to provide patients with early, accurate, and informative diagnoses. Founded in 2014, the company is headquartered in La Jolla, California, and operates research and development centers in Shanghai, China.

Silexon Intelligent Technology Co., Ltd. is a company based in Nanjing, China, dedicated to enhancing drug discovery through artificial intelligence. Founded in 2018, Silexon integrates extensive drug-related big data with AI methodologies to optimize the drug development process. The company offers a range of services tailored for pharmaceutical firms, including drug target panorama reports, personalized cell therapy, and small molecule virtual screening. Additionally, Silexon specializes in AI technologies such as drug repositioning platforms and macromolecular design models, providing valuable technical and data analysis support for generic drug research. Through its innovative approach, Silexon aims to streamline and improve the efficiency of R&D programs in the pharmaceutical industry.

Its main business scope is medical device technology development and sales; biomedical technology development, technology transfer, technical consulting services; corporate marketing planning; market research; business information consulting; Management consulting services; self-operated and agent import and export business of various commodities and technologies.

Wolfman Medical Technology is a medical imaging equipment developer dedicated to medical imaging technology and brain

Xynomic Pharmaceuticals is engaged in the in-licensing, development, and commercialization of oncology drug candidates, primarily targeting cancers prevalent in China, the United States, and globally. The company's leadership comprises experienced executives who have previously held research and development roles at major biopharmaceutical firms. With a focus on creating a robust pipeline of clinical and pre-clinical oncology therapies, Xynomic leverages global resources to enhance the efficiency of its drug development processes. The firm aims to address significant medical needs in oncology by developing innovative treatments that can effectively combat various types of cancer.

Singlera Genomics Inc. specializes in developing genetic testing and molecular diagnostic technologies, particularly focusing on non-invasive methods. The company has created a methylation detection platform that enhances cancer screening for early tumor diagnosis and prevention. Its offerings include tumor diagnosis, personalized treatment options, non-invasive prenatal diagnosis, and pre-implantation genetic screening, along with customized scientific research services. With a commitment to precision medicine, Singlera Genomics aims to provide patients with early, accurate, and informative diagnoses. Founded in 2014, the company is headquartered in La Jolla, California, and operates research and development centers in Shanghai, China.

Shanghai Fourier Intelligence Co. Ltd. specializes in the development of exoskeleton and rehabilitation robotics products aimed at enhancing mobility and therapeutic outcomes for users with movement impairments. Key products include the ExoMotus X2, an exoskeleton robot designed for walking assistance, and the ArmMotus M2, which aids in arm rehabilitation, focusing on shoulder and elbow joint movement. The WristMotus M1-W facilitates normal wrist movements, while CycleMotus provides an intuitive interface for patients to continue rehabilitation at home after clinical discharge. Additionally, the company is involved in various initiatives such as the Fourier Intelligence Group Therapy (FiGT), the Fourier Intelligent Rehabilitation Hub (FiRH), and the Fourier Exoskeleton & Robotics Open Platform System (EXOPS), which are aimed at advancing education and development in exoskeleton and robotics systems. Founded in 2015 and based in Shanghai, Fourier Intelligence combines technology and design to address the needs of individuals with disabilities and enhance their quality of life.

Chao Ju Ophthalmology Hospital, established in 1988 and based in China, specializes in ophthalmic treatments, particularly laser and refractive eye surgeries. With over 30 years of experience in the field, the institution has developed a strong technical foundation, employing more than 2,000 professionals, including professors, researchers, and senior physicians. Additionally, the hospital operates over 100 medical clinics staffed by clinical professors, allowing it to provide comprehensive eye care services.

Shenzhen U-dental Corporation Limited operates a dental care facility in China, providing a wide range of dental services. These include preventative care like cleanings, sealants, digital X-rays, and fluoride treatments, alongside orthodontics such as braces and Invisalign. The clinic also specializes in oral surgery, particularly third molar extractions and dental implants. Pediatric dentistry services are offered, including cosmetic treatments, ceramic onlays, and composite fillings. Additionally, U-dental provides endodontic services like root canals and retreatments, as well as periodontics, which encompass grafts, crown lengthening, and scaling. The company also focuses on specialty training programs in implants and orthodontic care. Founded in 2006, U-dental is headquartered in Shenzhen, China.

KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company offers a comprehensive range of biological heart valves, focusing on minimally invasive solutions that enhance patient outcomes. Utilizing cutting-edge technologies, including anti-calcification, dry presentation, and leaflet thinning, KingstronBio aims to deliver innovative and effective products to the medical community, thereby addressing critical needs in cardiovascular care.